1101941

Gershwin Blyden, M.D. — FEI 3015468268

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hollywood, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance